Full Breakdown
Supreme Court Weighs Glyphosate Labeling Lawsuit Amid Trump-Era EPA Policies
4/30/2026, 2:00:00 AM
Supreme Court Hears Glyphosate Labeling Dispute
On April 28 2026 the Supreme Court heard *Monsanto Co. v. Durnell* (24-1068). The case asks whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state lawsuits that seek a cancer warning on Roundup, a glyphosate herbicide. Missouri plaintiff John Durnell won a $1.25 million verdict in 2023 for alleged non-Hodgkin lymphoma; Bayer, Monsanto’s owner, contends EPA approval bars the claim.
Background, Data & Timeline
Glyphosate is the world’s most used weedkiller. The WHO’s International Agency for Research on Cancer labeled it “probably carcinogenic” in 2015, while the EPA has repeatedly found no public-health risk. Over 100,000 lawsuits have been filed; Bayer has earmarked $11.25 billion for settlements and $16 billion for pending claims. Key dates: 2015 IARC classification; 2023 Durnell verdict; Feb 2025 Trump executive order expanding glyphosate production; Apr 28 2026 Supreme Court hearing; decision expected July 2026.
Key Players
Bayer/Monsanto (Paul Clement), EPA Administrator Lee Zeldin, MAHA activists Vani Hari, Kelly Ryerson, Alexandra Muñoz, Justice Department’s Sarah Harris, and Justices John Roberts and Ketanji Brown Jackson.
Official Statements & Responses
The EPA pledged “transparency and gold-standard science” and said it takes MAHA’s concerns seriously. Bayer said a favorable ruling would give essential regulatory clarity. The Trump order called glyphosate production a national-security priority.
Criticism & Opposition
MAHA activists claim the administration “protects poison while urging real food.” Vani Hari warned, “You cannot claim to care about health while protecting poison.” Critics cite EPA’s dismantling of toxic-chemical research.
Conflicting Reports & Gaps
The IARC’s probable-carcinogen label conflicts with the EPA’s conclusion that glyphosate is unlikely carcinogenic. Legal scholars disagree whether FIFRA’s uniformity clause preempts state labeling suits.
Why It Matters
The decision will determine whether states can impose cancer warnings on federally approved pesticides, affecting regulatory uniformity, liability exposure for manufacturers, and potentially the cost and availability of glyphosate for U.S. agriculture.
Verbatim Quotes
- “You cannot claim to care about health while protecting poison. You cannot tell Americans to eat real food while protecting the cancer-causing chemicals sprayed on it,” — Vani Hari, Food Babe, MAHA activist
- “Congress plainly wanted uniformity when it came to the safety warnings on a pesticide label” — Paul Clement, attorney for Monsanto/Bayer
- “it’s not necessarily the case that they’re doing something inconsistent with what EPA would do.” — Chief Justice John Roberts
- “, FIFRA does not say, according to Keller, that a company can cite the EPA’s review of a label to fend off state-level misbranding lawsuits.” — Ashley Keller, attorney for John Durnell
- “What I see is an administration scrambling to try to give this grassroots base a bone, and I don't think they're buying it because they're actually following these issues,” — Sarah Vogel, Environmental Defense Fund
What’s Next
The Court will issue its opinion by early July 2026, shaping future pesticide labeling and litigation.
